DermaSensor

Skin cancer is one of the most common types of cancer, and early detection can make a major difference in outcomes.

For primary care providers, routine visits can be an important opportunity to identify suspicious lesions and take action sooner.

DermaSensor brings objective, AI-powered skin cancer risk assessment to the point of care to help support confident next-step decisions.

Ready to strengthen skin cancer detection in your practice? Visit the link in bio to learn more or request a demo.

Summer may be winding down, but the effects of sun exposure can stay with us.
As fall wellness visits and annual physicals pick up, it’s a timely opportunity to make skin checks part of comprehensive care, especially when a suspicious lesion comes up during a routine exam.

DermaSensor is built for clinical settings, combining elastic scattering spectroscopy technology with artificial intelligence to support clinicians with an immediate result at the point of care.

Make skin health part of the conversation this fall.
Learn more about DermaSensor at dermasensor.com

Primary care is often where suspicious skin lesions are first noticed and where important referral decisions begin.

DermaSensor brings objective, real-time information into the exam room to support clinical decision-making when it matters most.

See how DermaSensor can help strengthen skin cancer risk assessment in your practice. Visit the link in bio to learn more.

More practices are making room for DermaSensor and the clinical value speaks for itself.

With 96% sensitivity, FDA clearance, non-invasive technology, and immediate results, DermaSensor gives clinicians objective information to support skin cancer risk assessment right at the point of care.

Built for real clinical settings. Designed to support confident decisions without slowing down the visit.

See how DermaSensor can fit into your practice. Visit the link in bio to learn more

Summer may be winding down, but UV damage doesn’t disappear with the season. ☀️

Sun exposure adds up over time, and repeated sunburns can significantly increase the risk of skin cancer, including melanoma.

Keep paying attention to your skin year-round, especially any spots that are new, changing, or concerning.

If a suspicious lesion raises a question, DermaSensor gives clinicians an AI-powered, non-invasive tool to support skin cancer risk assessment in real time.

Find a DermaSensor provider near you or learn more at the link in bio.

Health equity matters in skin cancer detection.

As AI-powered technologies become more common in healthcare, it’s important to understand how different technologies work—and how they perform across diverse patient populations.

Unlike image-based AI tools, DermaSensor uses AI-powered Elastic Scattering Spectroscopy (ESS) to analyze 47 wavelengths and the spectral characteristics of suspicious skin lesions.

In the DERM-SUCCESS pivotal study, DermaSensor demonstrated 95.5% overall sensitivity across 1,579 suspicious lesions, with a subanalysis showing 96.5% sensitivity in Fitzpatrick Skin Types I–III and 92.2% in Types IV–VI.

While less melanoma sensitivity data are currently available for Fitzpatrick Skin Types IV–VI, DermaSensor is committed to continuing to build clinical evidence across diverse patient populations.

Because advancing health equity requires not only innovative technology, but continued evidence to support it.

Learn more about DermaSensor’s clinical evidence.

The best way to understand DermaSensor’s impact? Hear it directly from the physicians using it in practice.

Primary care physicians and specialists across the country are sharing how DermaSensor supports greater confidence when assessing suspicious skin lesions, strengthens clinical decision-making, and helps create clearer conversations with patients.

See what providers are saying and discover how DermaSensor can fit into your practice.

Ready to bring DermaSensor to your patients? Visit the link in bio to learn more or request a demo.

Source: dermasensor.com

September means fuller schedules, faster visits, and more decisions to make at the point of care.

DermaSensor is designed to fit into everyday clinical workflows, giving providers an AI-powered, non-invasive tool to help assess suspicious skin lesions in real time and support confident next-step decisions.

As practices head back into busy season, the right technology can help teams work more efficiently without adding unnecessary complexity.

Ready to bring AI-powered skin assessment into your practice? Learn more about DermaSensor.

September is National Skin Care Awareness Month - a reminder to make skin health part of everyday care.

Daily maintenance, regular skin checks, and early attention to suspicious changes all matter.

Patients: check your skin and speak with your provider about anything new or changing.

Providers: see how DermaSensor can support skin cancer risk assessment at the point of care.

Learn more or find a provider at the link in bio.